115 Views

New Drug Updates: Hematologic Malignancies

Sunday, November 6, 2022

Location: On-Demand

CE: 1 credit/contact hour

Speaker(s)

Restate the approved label indications of new drugs and biologics in hematology/oncology.
Describe the mechanisms of action for recently approved drugs and biologics in hematology/oncology.
Develop plans to monitor and manage side effects associated with administration of newly approved drugs and biologics in hematology/oncology.